Header Logo

Connection

RIMA M SALIBA to Antibodies, Neoplasm

Back to Details
This is a "connection" page, showing publications RIMA M SALIBA has written about Antibodies, Neoplasm.
RIMA M SALIBA
Connection Strength
0.053
Antibodies, Neoplasm
  1. Low-dose alemtuzumab (Campath) in myeloablative allogeneic stem cell transplantation for CD52-positive malignancies: decreased incidence of acute graft-versus-host-disease with unique pharmacokinetics. Bone Marrow Transplant. 2004 Apr; 33(8):833-7.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.